81 |
Cetuximab-related Hypersensitivity Reactions in Northeast TennesseeAngles, M., Bossaer, John B. 01 March 2012 (has links)
Primary Objective: To confirm the findings of several small studies conducted in the southeastern United States showing hypersensitivity infusion reaction (HIR) rates as high as 22% with the monoclonal antibody, cetuximab. Although well known for a risk of HIRs, early clinical studies showed much lower reaction rates of 3%.
|
82 |
Development of a Monitoring Parameters Guideline for Targeted Therapy in Renal Cell CarcinomaBryant, S. L., Bossaer, John B. 01 December 2010 (has links)
No description available.
|
83 |
Thyroid Dysfunction with Targeted Chemotherapy AgentsBossaer, John B. 22 October 2012 (has links)
1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.
|
84 |
Incidence and Treatment of Vancomycin-Resistant Enterococci (VRE) Infection in VRE Colonized Febrile Neutropenic PatientsBossaer, John B. 01 April 2009 (has links)
No description available.
|
85 |
Pemetrexed Induced Acute Kidney Injury and a Review of the Literature: a Case ReportParker, S. M., Bossaer, John B. 01 December 2017 (has links)
No description available.
|
86 |
Encounters with Immunologic Agents in General PracticePatel, N., Messmer, G., Bossaer, John B. 01 November 2016 (has links)
No description available.
|
87 |
Incidence of Cetuximab-related Infusion Reactions in Northeastern TennesseeAdams, C. B., Street, D. S., Bossaer, John B. 01 March 2015 (has links)
No description available.
|
88 |
Incidence of Cetuximab-related Infusion Reactions in Northeastern TennesseeAdams, C. B., Street, D. S., Bossaer, John B. 01 December 2014 (has links)
No description available.
|
89 |
Alternative Treatment of Hodgkin’s Lymphoma in a Patient with Severe Hepatic ImpairmentTorrence, A. M., Bossaer, John B. 01 December 2013 (has links)
No description available.
|
90 |
Patient Use of Herbal Supplements in an Outpatient Hematology/Oncology Medical ClinicThomas, C. M., Bossaer, John B. 01 March 2012 (has links)
Primary Objective: According to the National Center for Health Statistics, many Americans use some type of vitamin or supplement. A recent study of cancer patients in the VA medical system found that a significant number of cancer patients do not mention the use of supplements to their healthcare providers. Many of these supplements were also found to interact with or compound side effects of chemotherapy regimens. The purpose of this study is to determine the incidence of cancer patients taking supplements and to determine the completeness of home medication lists in regard to vitamins or herbal supplements.
|
Page generated in 0.0735 seconds